You are here

Robert W. Atcher, PhD, MBA
 - Robert Atcher
Molecular Imaging

During my term as president of the Society of Nuclear Medicine (And Molecular Imaging, now appended), we were in the midst of the Molecular Imaging Campaign that was successful in increasing the visibility of nuclear medicine as a measure of physiologic and metabolic parameters in diagnosing our patients.

 - Robert W. Atcher, PhD, MBA
Molecular Imaging

During the past five years, I have spent a considerable amount of time on the issue of supply of Tc-99m and its parent, Mo-99.

 - Robert Atcher
Molecular Imaging

I have been thinking lately about issues related to the direction of research funding for the field of molecular imaging. I have to confess my preference for nuclear techniques in this regard since tracer techniques usually have the advantage of not perturbing the observed state. 

 - Robert W. Atcher, PhD, MBA
Molecular Imaging

When I began my PhD research almost 40 years ago, nuclear medicine research was almost entirely focused on diagnosis. 

 - Robert W. Atcher, PhD, MBA
Molecular Imaging

This spring and summer was a very busy one in the field of molecular imaging. Starting in May, we had the International Society of Radiopharmaceutical Sciences meeting in Jeju, South Korea. 

 - Robert W. Atcher, PhD, MBA
Molecular Imaging

I have been struggling recently with the notion that genomics is going to revolutionize our ability to diagnose and treat disease. Why? A basic tenet of information theory is simple: the more precisely you can measure something, the less information it contains.

 - Robert W. Atcher, PhD, MBA
Molecular Imaging

I have been talking to various audiences over the past five years about the potential of molecular imaging in the care of our patients.